跳至主要内容
临床试验/JPRN-UMIN000022071
JPRN-UMIN000022071已完成未知

The follow-up study of social anxiety symptom in patients with schizophrenia - The follow-up study of social anxiety symptom in patients with schizophrenia

Medical Affairs Otsuka Pharmaceutical Co., Ltd.0 个研究点目标入组 118 人开始时间: 2016年4月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
118

研究概览

简要总结

Stepwise multiple regressions examining the change in social functioning using demographic data and changes in clinical variables as explanatory variables demonstrated that the changes in social anxiety and general psychopathology contributed to the change in the SFS. Stepwise multiple regressions for the change in QOL demonstrated that the changes in social anxiety and depression contributed to the change in the WHO QOL scale, and the changes in social anxiety and positive symptoms contributed to the SWNS.

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
Medical Affairs Otsuka Pharmaceutical Co., Ltd.

相似试验